What departments does MoonLake Immunotherapeutics (NASDAQ: MLTX) have?

MoonLake Immunotherapeutics (NASDAQ: MLTX) has employees across 10 departments including Finance, Engineering, Marketing, Information Technology, Operations.

What is the largest department at MoonLake Immunotherapeutics (NASDAQ: MLTX)?

The largest department at MoonLake Immunotherapeutics (NASDAQ: MLTX) is Operations with 8 employees.

Where are MoonLake Immunotherapeutics (NASDAQ: MLTX) employees located globally?

MoonLake Immunotherapeutics (NASDAQ: MLTX) has employees across 4 continents and 12 countries including United Kingdom Of Great Britain And Northern Ireland, Switzerland, Portugal, Ireland, France.

How has MoonLake Immunotherapeutics (NASDAQ: MLTX)'s team size changed over time?

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s team has decreased from approximately 130 to 125 employees based on available data.

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Directory

Biotechnology ResearchZug, Switzerland51-200 Employees

MoonLake Immunotherapeutics AG is a clinical-stage biotechnology company based in Zug, Switzerland, focused on developing therapies for immune-related diseases. It leverages Nanobody technology to advance treatments for inflammatory skin and joint conditions. The firm operates at a mid-sized scale, with its activities centered on research and clinical development in the biopharmaceutical field.

In 2026, MoonLake entered into a Master Commercial Supply Agreement with Vetter Pharma International to manufacture pre-filled administration systems for its drug candidates, supporting its product pipeline including sonelokimab. The company concentrates its efforts on immunologic diseases, with an emphasis on dermatologic and rheumatologic conditions.

MoonLake Immunotherapeutics (NASDAQ: MLTX) Global Highlights

Europe
129

United Kingdom Of Great Britain And Northern Ireland
49
Portugal
43
Switzerland
29
Italy
2
Belgium
2
Ireland
1
France
1
Spain
1
Germany
1

North America
2

United States Of America
2

Oceania
1

Australia
1

South America
1

Brazil
1

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s Leadership

M. B.
Chief Financial Officer
Mobile Phone
Email
O. D.
Chief Technical Officer
Mobile Phone
Email
W. O. B.
Chief Medical Officer
Mobile Phone
Email
N. B.
Chief Clinical Development Officer
Mobile Phone
Email
M. R. A.
Chief Of Staff To The Executive Board
Mobile Phone
Email
T. A.
Vp Marketing, Market Access & Pricing
Mobile Phone
Email
J. F. M.
Vice President Clinical Development
Mobile Phone
Email
J. S. D. S.
Founder & Chief Executive Officer
Mobile Phone
Email

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Metrics

100%

50%

0%

2026

2025

Administrative
Business
Legal
Human Resources
Program & Project Management
Other
Biotechnology
Information Technology

Contact profiles from MoonLake Immunotherapeutics (NASDAQ: MLTX)

Name

Title

Contact Info

Location

Last Update

J. S. D. S.
Founder & Chief Executive Officer
Mobile Phone
Email
SwitzerlandCanton of Zug
Jun 19, 2026
M. B.
Chief Financial Officer
Mobile Phone
Email
SwitzerlandZug
Jun 07, 2026
O. D.
Chief Technical Officer
Mobile Phone
Email
Switzerland
Jun 15, 2026
K. R.
Co-Founder And Chief Scientific Officer
Mobile Phone
Email
Switzerland
Jun 15, 2026
A. P.
Founder
Mobile Phone
Email
Switzerland
Jun 15, 2026
W. O. B.
Chief Medical Officer
Mobile Phone
Email
Switzerland
May 04, 2026
N. B.
Chief Clinical Development Officer
Mobile Phone
Email
United Kingdom
Jun 26, 2026
T. A.
Vp Marketing, Market Access & Pricing
Mobile Phone
Email
SwitzerlandZurich
Jun 15, 2026
J. D.
Associate Vice President, Head Of Information Technology
Mobile Phone
Email
SwitzerlandCanton of Zug
Mar 24, 2026
M. R. A.
Chief Of Staff To The Executive Board
Mobile Phone
Email
GermanyNorth Rhine-Westphalia
Jan 13, 2026

Frequently Asked Questions

What is MoonLake Immunotherapeutics (NASDAQ: MLTX) known for?

MoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021 operates in the Biotechnology Research industry. The company's main headquarters is located in 29 Dorfstrasse Zug, Zug Switzerland. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s company overview page for more information.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s most common email format?

MoonLake Immunotherapeutics (NASDAQ: MLTX) employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more MoonLake Immunotherapeutics (NASDAQ: MLTX) email formats with LeadIQ.

How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have currently?

MoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 134 employees as of June 2026. These team members are located across 4 continents, including EuropeNorth AmericaOceania.

Who are MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees and leadership?

As of June 2026, MoonLake Immunotherapeutics (NASDAQ: MLTX)'s key employees include:

Chief Financial Officer: M. B.
Chief Technical Officer: O. D.
Chief Medical Officer: W. O. B.
Chief Clinical Development Officer: N. B.
Chief Of Staff To The Executive Board: M. R. A.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

MoonLake Immunotherapeutics (NASDAQ: MLTX) Employee Directory

Find MoonLake Immunotherapeutics (NASDAQ: MLTX) employees' phone numbers or email addresses

Name search is limited — try advanced search instead